947 Results
FDA Approves Novel Depression Treatment
Last month, esketamine nasal spray became the first treatment for depression with a new mechanism of action approved by the Food and Drug Administration (FDA) since Prozac (fluoxetine hydrochloride) was approved in the late 1980s. Esketamine (sold as Spravato) has the potential to be extremely useful for people who have not responded to other treatments. Used in combination with an oral anti-depressant, it can take effect much faster than many common antidepressant medications. However, it comes
Statement from the American Psychiatric Association on Firearm Violence
The American Psychiatric Association (APA) condemns the senseless loss of lives from firearm violence that has become all too common in this country, most recently in mass shootings in Uvalde, Buffalo, Houston and more than 200 other locations across the country in 2022 so far.
APA Statement on CDC Report on Deaths From Overdose
The Centers for Disease Control and Prevention today reported that between April 2020 and April 2021, U.S. deaths from overdoses topped 100,000. This grim milestone constitutes a record, and overall, these deaths are up 29 percent from the prior year. Today, the American Psychiatric Association reiterates that effective treatments for substance use disorder are available, and renews its calls for action.
DEA Special Registration for Telemedicine
On January 15, the DEA released a proposed rule for special registration related to prescribing controlled substances via telemedicine when the prescribing practitioner has never conducted an in-person medical evaluation of the patient prior to the issuance of the prescription.
What Is Narcissistic Personality Disorder?
Many people may be familiar with the casual use of the term narcissist, referring to a person who is very self-centered, boastful and hungry for attention and admiration. However, narcissistic personality disorder, a condition described in the DSM-5-TR*, is more severe, persistent and problematic.
A Message from the APA on COVID-19
As the U.S. addresses COVID-19 (coronavirus), all medical associations are working to ensure the continued operations of their respective organizations, governing bodies, assemblies, boards, meetings, and conferences.
American Psychiatric Association Publishes Updated Guideline on Eating Disorders and Accompanying Implementation Tools
The American Psychiatric Association (APA) recently published an updated practice guideline for treatment of patients with eating disorders. The guideline provides recommendations on assessment and evidence-based pharmacological, psychotherapeutic, and other nonpharmacological treatments for eating disorders. The Practice Guideline for the Treatment of Patients with Eating Disorders focuses primarily on anorexia nervosa, bulimia nervosa, and binge-eating disorder and includes new tips for scree
Exploring a Strengths-Based Approach to Neurodiversity
April is Autism Acceptance Month, drawing attention to the needs and concerns of people on the autism spectrum and other neurodiverse individuals. A new book, “Neurodiversity: From Phenomenology to Neurobiology and Enhancing Technologies,” explores a strengths-based approach to a broad array of neurodiversity.
Researchers Explore New Technologies to Help People with Autism
Researchers are exploring new ways to use technology to help children and adults with autism. For example, the University of California’s MIND Institute has a targeted program, Autism, Community and Technology, that is working to help make autism services and treatments more accessible and affordable for families in need through technology.
Top Diversity and Equity Leaders in Psychiatry Offer Guidelines for Academic Medicine in New Article and Commentary from American Journal of Psychiatry
Diversity, equity and inclusion (DEI) leaders in academic medicine are subject to increasing expectations with limited resources and there is an urgent need for psychiatry departments to commit to fully supporting their efforts, according to an article now available in the American Journal of Psychiatry written by top DEI leaders in academic psychiatry from across the country.
Dr. Steven Chan Interviews Dr. Iverson Bell About His Experience with Telepsychiatry
Dr. Steven Chan interviews Dr. Iverson Bell about how his experiences with telehealth have evolved over the years to present day, barriers to implementation, and discusses his hopes and expectations for the future of telepsychiatry.
Twelve-Step-Based Programs Effective for Substance Use Problems
Spiritual or religious based programs, such as those based on the principles of Alcoholics Anonymous, are effective for treating people with substance use disorders, according to the first systematic review of such programs. In the U.S., more than 20 million people 12 years and older (about 7.4%) have a substance use disorder and among 18-to-25-year-olds, 15% have a substance use disorder, according to the 2018 National Survey on Drug Use and Health.